RBC Capital Mkts initiated coverage on IQVIA with a new price target

9/4/24 8:11:38 AM ET

Biotechnology: Commercial Physical & Biological Resarch

Health Care

RBC Capital Mkts initiated coverage of IQVIA with a rating of Outperform and set a new price target of $275.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$IQV

Date	Price Target	Rating	Analyst
4/25/2025	$160.00	Buy → Hold	HSBC Securities
4/10/2025	$170.00	Overweight → Equal Weight	Barclays
2/3/2025		Buy → Neutral	BTIG Research
12/20/2024	$250.00	Overweight	Stephens
10/14/2024		Buy	Redburn Atlantic
9/4/2024	$275.00	Outperform	RBC Capital Mkts
7/24/2024	$266.00 → $242.00	Buy → Hold	Jefferies
6/6/2024	$270.00	Buy	Goldman